Across TCGA pan-cancer cohorts, RNU6ATAC27P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNU6ATAC27P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RNU6ATAC27P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6ATAC27P is over-expressed in tumor, although a few such as KICH and COAD show the opposite, repressed pattern.

UCEC, LUSC, and KICH are the cancer types where RNU6ATAC27P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6ATAC27P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	+0.708	.005	6	view →
LUSC	All	II,III,IV	+0.574	<.001	6	view →
KICH	All	All	−0.253	.002	5	view →
BLCA	Female	IV	+0.913	.019	1	view →
COAD	All	III,IV	−0.307	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNU6ATAC27P RNA expression & survival · all RNU6ATAC27P data types